These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16546856)

  • 21. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC; Kawamoto CT; Bottomley A; Efficace F
    J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Including persons with HIV infection in cancer clinical trials.
    Persad GC; Little RF; Grady C
    J Clin Oncol; 2008 Mar; 26(7):1027-32. PubMed ID: 18309938
    [No Abstract]   [Full Text] [Related]  

  • 23. Incorporation of geriatric principles in oncology clinical trials.
    Hurria A
    J Clin Oncol; 2007 Dec; 25(34):5350-1. PubMed ID: 18048814
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
    Ohorodnyk P; Eisenhauer EA; Booth CM
    Eur J Cancer; 2009 Sep; 45(13):2249-52. PubMed ID: 19545996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptom control trials: a 20-year experience.
    Loprinzi CL; Barton DL; Jatoi A; Sloan J; Martenson J; Steensma D; Rao R; Novotny P; Sood A; Grothey A; Minasian L; Windschitl H
    J Support Oncol; 2007 Mar; 5(3):119-25, 128. PubMed ID: 17410810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer patients' attitudes toward clinical trials in the radiation oncology clinic versus those searching for trial information on the Internet.
    Dolinsky CM; Wei SJ; Hampshire MK; Metz JM
    Breast J; 2006; 12(4):324-30. PubMed ID: 16848841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update in methodology and conduct of cancer clinical trials.
    Therasse P; Eisenhauer EA; Buyse M
    Eur J Cancer; 2006 Jul; 42(10):1322-30. PubMed ID: 16737813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
    Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
    J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successfully improving access and accrual to oncology clinical trials.
    Nott L; Yeend S; Pirc L; Pittman K; Patterson K; Price TJ
    Cancer; 2007 Apr; 109(8):1451-3. PubMed ID: 17330840
    [No Abstract]   [Full Text] [Related]  

  • 30. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
    Dilts DM; Sandler AB; Baker M; Cheng SK; George SL; Karas KS; McGuire S; Menon GS; Reusch J; Sawyer D; Scoggins M; Wu A; Zhou K; Schilsky RL;
    J Clin Oncol; 2006 Oct; 24(28):4553-7. PubMed ID: 17008694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer in the elderly: a societal perspective from the United States.
    Muss HB
    Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):92-8. PubMed ID: 19059768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
    Steensma DP
    J Clin Oncol; 2007 Mar; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
    [No Abstract]   [Full Text] [Related]  

  • 33. A model for managing patient booking in a radiotherapy department with differentiated waiting times.
    Thomsen MS; Nørrevang O
    Acta Oncol; 2009; 48(2):251-8. PubMed ID: 18759136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Various pitfalls in cancer clinical trials].
    Sakamoto J; Matsui T; Kodera Y
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):161-70. PubMed ID: 19223730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms linking physical activity with cancer.
    McTiernan A
    Nat Rev Cancer; 2008 Mar; 8(3):205-11. PubMed ID: 18235448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Veterinary oncology: Fido and Fluffy get latest cancer treatments.
    Mahaney FX
    J Natl Cancer Inst; 1989 Dec; 81(24):1859-61. PubMed ID: 2687476
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethical considerations in pediatric oncology phase I clinical trials according to The Belmont Report.
    Haylett WJ
    J Pediatr Oncol Nurs; 2009; 26(2):107-12. PubMed ID: 19190176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncology. In their prime, and dying of cancer.
    Couzin J
    Science; 2007 Aug; 317(5842):1160-2. PubMed ID: 17761859
    [No Abstract]   [Full Text] [Related]  

  • 39. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
    Ansell JE
    Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative criteria used in clinical oncology].
    Fiorentino M
    Cancro; 1970; 23(1):5-21. PubMed ID: 5517837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.